Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
14.63
+0.38 (2.67%)
At close: Mar 6, 2026, 4:00 PM EST
14.80
+0.17 (1.16%)
After-hours: Mar 6, 2026, 7:07 PM EST
Fulgent Genetics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 322.67 | 283.47 | 289.21 | 618.97 | 992.58 | Upgrade
|
| Revenue Growth (YoY) | 13.83% | -1.99% | -53.27% | -37.64% | 135.37% | Upgrade
|
| Cost of Revenue | 191.8 | 176.26 | 184.76 | 252.07 | 215.53 | Upgrade
|
| Gross Profit | 130.88 | 107.22 | 104.46 | 366.9 | 777.05 | Upgrade
|
| Selling, General & Admin | 158.11 | 124.35 | 130.47 | 149.99 | 75.17 | Upgrade
|
| Research & Development | 53.91 | 48.82 | 41.44 | 28.91 | 24.22 | Upgrade
|
| Amortization of Goodwill & Intangibles | 8.03 | 7.97 | 7.85 | 6.5 | 1.71 | Upgrade
|
| Operating Expenses | 220.05 | 181.13 | 179.75 | 185.4 | 101.1 | Upgrade
|
| Operating Income | -89.17 | -73.92 | -75.3 | 181.5 | 675.95 | Upgrade
|
| Interest Expense | -0.08 | - | -0.49 | -1.01 | -0.18 | Upgrade
|
| Interest & Investment Income | 30.92 | 31.3 | 21.61 | 5.62 | 0.34 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.15 | 0.73 | 0.32 | 0.89 | - | Upgrade
|
| EBT Excluding Unusual Items | -58.18 | -41.88 | -53.85 | 187 | 676.11 | Upgrade
|
| Merger & Restructuring Charges | -1.92 | - | - | -2.98 | - | Upgrade
|
| Impairment of Goodwill | - | - | -120.23 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | 4.92 | Upgrade
|
| Asset Writedown | -9.93 | -10.07 | - | - | - | Upgrade
|
| Pretax Income | -70.03 | -51.96 | -174.09 | 184.03 | 681.03 | Upgrade
|
| Income Tax Expense | -8.39 | -8.14 | 1.15 | 42.1 | 174.8 | Upgrade
|
| Earnings From Continuing Operations | -61.63 | -43.82 | -175.24 | 141.92 | 506.24 | Upgrade
|
| Net Income to Company | -61.63 | -43.82 | -175.24 | 141.92 | 506.24 | Upgrade
|
| Minority Interest in Earnings | 1.12 | 1.11 | 7.41 | 1.48 | 1.13 | Upgrade
|
| Net Income | -60.51 | -42.71 | -167.83 | 143.4 | 507.36 | Upgrade
|
| Net Income to Common | -60.51 | -42.71 | -167.83 | 143.4 | 507.36 | Upgrade
|
| Net Income Growth | - | - | - | -71.74% | 136.74% | Upgrade
|
| Shares Outstanding (Basic) | 31 | 30 | 30 | 30 | 29 | Upgrade
|
| Shares Outstanding (Diluted) | 31 | 30 | 30 | 31 | 31 | Upgrade
|
| Shares Change (YoY) | 1.79% | 1.51% | -3.81% | -0.04% | 28.77% | Upgrade
|
| EPS (Basic) | -1.97 | -1.41 | -5.63 | 4.76 | 17.25 | Upgrade
|
| EPS (Diluted) | -1.97 | -1.41 | -5.63 | 4.63 | 16.38 | Upgrade
|
| EPS Growth | - | - | - | -71.73% | 83.84% | Upgrade
|
| Free Cash Flow | -124.21 | -19.26 | 4.8 | 234.75 | 514.77 | Upgrade
|
| Free Cash Flow Per Share | -4.04 | -0.64 | 0.16 | 7.58 | 16.62 | Upgrade
|
| Gross Margin | 40.56% | 37.82% | 36.12% | 59.28% | 78.29% | Upgrade
|
| Operating Margin | -27.64% | -26.08% | -26.03% | 29.32% | 68.10% | Upgrade
|
| Profit Margin | -18.75% | -15.07% | -58.03% | 23.17% | 51.12% | Upgrade
|
| Free Cash Flow Margin | -38.50% | -6.79% | 1.66% | 37.92% | 51.86% | Upgrade
|
| EBITDA | -65.05 | -48.99 | -49.15 | 214.16 | 686.96 | Upgrade
|
| EBITDA Margin | -20.16% | -17.28% | -16.99% | 34.60% | 69.21% | Upgrade
|
| D&A For EBITDA | 24.12 | 24.93 | 26.14 | 32.66 | 11 | Upgrade
|
| EBIT | -89.17 | -73.92 | -75.3 | 181.5 | 675.95 | Upgrade
|
| EBIT Margin | -27.63% | -26.08% | -26.03% | 29.32% | 68.10% | Upgrade
|
| Effective Tax Rate | - | - | - | 22.88% | 25.67% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.